DongKook Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was KRW 14,571.34 million compared to KRW 21,080.69 million a year ago. Net income was KRW 47,175.2 million compared to KRW 52,895.93 million a year ago.

Basic earnings per share from continuing operations was KRW 1,073 compared to KRW 1,203 a year ago. Diluted earnings per share from continuing operations was KRW 1,055 compared to KRW 1,183 a year ago. Basic earnings per share was KRW 1,073 compared to KRW 1,203 a year ago.

Diluted earnings per share was KRW 1,055 compared to KRW 1,183 a year ago.